IL53462A0 - Prolonged release pharmaceutical preparations - Google Patents

Prolonged release pharmaceutical preparations

Info

Publication number
IL53462A0
IL53462A0 IL53462A IL5346277A IL53462A0 IL 53462 A0 IL53462 A0 IL 53462A0 IL 53462 A IL53462 A IL 53462A IL 5346277 A IL5346277 A IL 5346277A IL 53462 A0 IL53462 A0 IL 53462A0
Authority
IL
Israel
Prior art keywords
pharmaceutical preparations
release pharmaceutical
prolonged release
prolonged
preparations
Prior art date
Application number
IL53462A
Other versions
IL53462A (en
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of IL53462A0 publication Critical patent/IL53462A0/en
Publication of IL53462A publication Critical patent/IL53462A/en
Priority to IL74505A priority Critical patent/IL74505A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
IL53462A 1976-11-26 1977-11-24 Prolonged release pharmaceutical preparations containing ion exchange drug complexes IL53462A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL74505A IL74505A (en) 1977-11-24 1985-03-05 Controlled release pharmaceutical preparations containing ion exchange resin particles which were pre-treated with glycerin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
IL53462A0 true IL53462A0 (en) 1978-01-31
IL53462A IL53462A (en) 1980-12-31

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53462A IL53462A (en) 1976-11-26 1977-11-24 Prolonged release pharmaceutical preparations containing ion exchange drug complexes

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
WO2019074829A1 (en) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. Pharmaceutical resinate compositions and methods of making and using thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Also Published As

Publication number Publication date
FR2373288B1 (en) 1980-06-13
JPS609697B2 (en) 1985-03-12
NO147626C (en) 1983-05-25
ATA848077A (en) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (en) 1988-02-16
CA1086226A (en) 1980-09-23
DE2752728A1 (en) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (en) 1980-05-15
DK150534C (en) 1987-10-12
DK523277A (en) 1978-05-27
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (en) 1983-02-14
FI773568A (en) 1978-05-27
SE7713370L (en) 1978-05-27
DE2752728C2 (en) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (en) 1980-10-27
BE861141A (en) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (en) 1984-08-10
FI65910B (en) 1984-04-30
NO147626B (en) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (en) 1987-09-16
LU78584A1 (en) 1978-04-20
IE45998B1 (en) 1983-01-26
NL7712996A (en) 1978-05-30
NO774051L (en) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (en) 1978-07-07
DK150534B (en) 1987-03-23

Similar Documents

Publication Publication Date Title
ZA783480B (en) New pharmaceutical preparations
ZA803567B (en) Pharmaceutical preparations
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
NZ180321A (en) Sustained release pharmaceutical preparation
JPS5372814A (en) Pharmaceutical composition
AU515157B2 (en) Sustained release medicament
AU3152677A (en) Pharmaceutical composition
GR61724B (en) Prolonged release pharmaceutical preparations
JPS52128357A (en) Antiitumor drug
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
HU175384B (en) Insecticide preparations
GB1541710A (en) Anthelintic preparations
JPS5283918A (en) Pharmaceutical composition
MY8400062A (en) Pharmaceutical preparations for venotonic use
ZA776645B (en) Pharmaceutical preparations
AU3149277A (en) D-homosteroids and pharmaceutical preparation
JPS5338620A (en) Isomalin antiimold drug
ZA777335B (en) Pharmaceutical compounds
JPS52122633A (en) Pharmaceutical composition
ZA776104B (en) Cosmetic preparations
ZA7627B (en) Pharmaceutical combination preparations
BG23572A1 (en) Medicinal preparation